Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanislas Pol

Showing results (411-420 of 441) with videos related to

Pageof 45
Sort By:
Joint Bone Spine|June 28, 2011
TNF alpha antagonist therapy and safety monitoringThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
Gastroenterology|July 31, 2012
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infectionEtienne Patin, Zoltán Kutalik, Julien Guergnon, et al.
Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort studyLaurent Lam, Hélène Fontaine, Marc Bourliere, et al.
BMC Infectious Diseases|January 28, 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosisGeorges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, et al.
Lancet (London, England)|February 16, 2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyFabrice Carrat, Hélène Fontaine, Céline Dorival, et al.
Journal of Hepatology|February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosisPierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2024
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohortVictor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, et al.
The Lancet. Gastroenterology & Hepatology|February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre studyJean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
The New England Journal of Medicine|March 8, 2018
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis BGonzague Jourdain, Nicole Ngo-Giang-Huong, Linda Harrison, et al.
Journal of Hepatology|May 15, 2013
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890Christophe Hézode, Hélène Fontaine, Céline Dorival, et al.
Pageof 45

Showing results (411-420 of 441) with videos related to

Sort By:
Pageof 45
Joint Bone Spine|June 28, 2011
TNF alpha antagonist therapy and safety monitoringThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
Gastroenterology|July 31, 2012
Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infectionEtienne Patin, Zoltán Kutalik, Julien Guergnon, et al.
Clinics and Research in Hepatology and Gastroenterology|April 30, 2021
Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort studyLaurent Lam, Hélène Fontaine, Marc Bourliere, et al.
BMC Infectious Diseases|January 28, 2022
Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosisGeorges-Philippe Pageaux, Clovis Lusivika Nzinga, Nathalie Ganne, et al.
Lancet (London, England)|February 16, 2019
Clinical outcomes in patients with chronic hepatitis C after direct-acting antiviral treatment: a prospective cohort studyFabrice Carrat, Hélène Fontaine, Céline Dorival, et al.
Journal of Hepatology|February 28, 2025
Value of non-invasive test dynamics in guiding HCC surveillance decisions after HCV cure in patients with cirrhosisPierre Nahon, Clovis Lusivika-Nzinga, Philippe Merle, et al.
JHEP Reports : Innovation in Hepatology|July 24, 2024
Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohortVictor de Lédinghen, Claire Fougerou-Leurent, Estelle Le Pabic, et al.
The Lancet. Gastroenterology & Hepatology|February 23, 2025
[<sup>18</sup>F]fluorodeoxyglucose and [<sup>18</sup>F]fluorocholine PET-CT for staging optimisation and treatment modification in hepatocellular carcinoma (PET-HCC01): a prospective multicentre studyJean-Charles Nault, Marouane Boubaya, Myriam Wartski, et al.
The New England Journal of Medicine|March 8, 2018
Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis BGonzague Jourdain, Nicole Ngo-Giang-Huong, Linda Harrison, et al.
Journal of Hepatology|May 15, 2013
Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890Christophe Hézode, Hélène Fontaine, Céline Dorival, et al.
Pageof 45